Educational information, not medical advice — ask your doctor or midwife.
Keishi-bukuryo-gan (KBG) is one of the most widely prescribed Kampo formulas in Japan, derived from the classical Chinese text 'Jin Gui Yao Lue' (Essentials of the Golden Cabinet) written around the 3rd century CE. It combines five botanicals that each contribute to its overall effect on circulation, inflammation, and hormonal balance. In modern Japan, it is available as a standardized over-the-counter and prescription-grade extract used by gynecologists and Kampo practitioners alike.
The formula is thought to improve blood flow to the pelvic region, reduce stagnation (a concept in both Chinese and Japanese medicine referring to sluggish circulation and fluid buildup), and gently modulate inflammation. Modern research suggests its herbs work together to lower prostaglandins that drive menstrual cramps, reduce oxidative stress, and influence estrogen metabolism — which may explain its effect on fibroids and menopausal symptoms. No single ingredient drives the effect; the combination is key.
In Japan, KBG is most commonly taken as standardized granules (dissolved in warm water) or tablets, with brand names like Tsumura TJ-25 being widely prescribed. Traditional decoctions (boiling the raw herbs) are still used by classical Kampo practitioners. Granule extracts are the most practical and well-studied form. Tablets offer convenience but may vary in standardization outside Japan.
This formula has been in continuous clinical use for over 1,700 years, first codified in Zhang Zhongjing's 'Jin Gui Yao Lue.' It was adopted into Japanese Kampo medicine and remains one of the top 10 most prescribed Kampo formulas in Japan today, used routinely in obstetrics and gynecology departments at major Japanese hospitals.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.